English
The entire site
Cannabis Social Club
Encod.org
European Coalition for Just and Effective Drug Policies (ENCOD)
Secretariat: Ploegstraat 27 – 2018 Antwerpen - Belgium
Tel: +32 (0)495 122 644
E-mail: office@encod.org

Home page > English (en) > EU LOBBY CAMPAIGN > 2008 > EU COMMISSION ANNOUNCES NEW ACTION PLAN ON DRUGS

EU COMMISSION ANNOUNCES NEW ACTION PLAN ON DRUGS

published Sunday 21 September 2008 23:25, by encod . update Monday 4 January 2010 10:16

All the versions of this article: [Deutsch] [English] [Español] [français] [Nederlands]

European Union

Press Release - IP/08/1366

Brussels, 18 September 2008


Today the Commission adopted an "EU Drugs Action Plan for 2009-2012" (also available in French, German, Bulgarian, Czech, Danish, Greek, Estonian, Spanish, Finnish, Hungarian, Italian, Lets, Lithuanian, Maltese, Dutch, Polish, Portuguese, Slovakian, Rumanian, Swedish and Slovenian which proposes wide-ranging measures to strengthen European cooperation to curb the adverse consequences of drug use and cut drug-related crime.

On 21 to 23 November, ENCOD members are preparing a workshop on the participation of drug users in the design of drug policies in general and the EU Action Plan in particular. In this workshop we will also formulate a common statement on this Action Plan.

"With up to 2 million problem drug users in the EU, it’s high time to raise awareness of vulnerable groups, especially youth, on the risks of drug taking" stated Vice-President Jacques Barrot, Commissioner responsible for Justice, Freedom and Security.

Latest available data show that whereas the use of heroin, cannabis and synthetic drugs has stabilised or is declining, cocaine use is rising in a number of Member States. The total number of people in the EU who use drugs – or have at some time taken them – is estimated at 70 million for cannabis, at least 12 million for cocaine, 9.5 million for ecstasy and 11 million for amphetamines, while at least half a million people are known to be receiving substitution treatment for heroin. There are up to 2 million problem drug users in the EU and around 7,500 people die of drug overdoses each year.

The Action Plan 2009-2012 builds on the existing approach of the EU Drugs Strategy 2005-2012 which set out a European model for drug policy based on a balanced approach to reduce both supply and demand for drugs.

It is based on an assessment of the expected impact that the Plan will have on the drug situation in Europe. This impact assessment is available in summary in English, French and German. Its entire version is only available in English.

The five main priorities of the new Action Plan include reducing the demand for drugs and raising public awareness, mobilising European citizens, reducing the supply of drugs, improving international cooperation and facilitating a better understanding of the drug phenomenon.

Actions proposed include measures to improve the quality, availability and coverage of treatment and harm reduction programmes for drug users and the establishment of intelligence-led police and customs operations to counter large-scale organised crime groups both in the EU and on the drug trafficking routes from Afghanistan and Latin America.

The EU Drugs Action Plan 2009-2012 will be presented to the Council and is expected to be adopted before the end of the year.

Background

What has European action on illicit drugs achieved so far?

The Action Plan 2009-2012 is based on an evaluation of the Action Plan 2005-2008 carried out by the Commission with the support of the Member States, the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA), Europol and European NGOs.

Achievements of the past years include a decrease in the number of drug-related deaths and in the spread of HIV through drug injecting. Overall Member States have implemented a broad range of responses to the drug problem, including prevention, treatment, harm reduction and rehabilitation and taken measures to reduce crimes such as drug trafficking and money laundering.

The evaluation confirms that, despite differences in approach, Member States are increasingly working closer together and that national drug policies are converging. At the international level, the EU has gained influence by operating as one body in UN drug fora and EU drug policy increasingly provides a model for countries worldwide.

Attached documents

Reply to this article

Site Map | Private area SSL NO SSL | WebMail SSL NO SSL | SPIP | Valid XHTML 1.0 Strict Backing documented is origin There
Backing documented is origin There
Backing documented is origin There
Backing documented is origin There